期刊文献+

吡喹酮水凝胶栓剂的制备及含量测定 被引量:7

Preparation and Content Determination of Praziquantel Aquogel Suppository
下载PDF
导出
摘要 目的:制备吡喹酮水凝胶栓剂,并建立其含量测定方法.方法:以正交试验法筛选基质最佳处方,采用紫外分光光度法测定主药吡喹酮的含量.结果:最佳基质处方为泊洛沙姆P407/P188(15%:20%)、海藻酸钠0.6%、乙醇15%,由此制得的吡喹酮水凝胶栓剂在体温下胶凝,粘度适中;吡喹酮检测浓度在0.2~1.0mg/ml范围内线性关系良好(r=0.9 999),平均加样回收率为(102.44±0.69)%.结论:该处方设计合理,制备工艺可靠,含量测定方法简便、快速、准确. OBJECTIVE: To prepare praziquantel aquogel suppositories and to establish its assay method. METHOD: The optimal formula of the base was optimized by orthogonal experiment and the content of principal agent -praziquantel was determined by UV spectrophotometry. RESULTS: The optimized formula of the base was as follows, poloxamer P407 : P188 (15% : 20% ), sodium alginate 0.6% and ethyl alcohol 15%, the praziquantel aquogel suppositories prepared in this formula could be jellified under the body temperature with optimal viscosity. Good linear relationship occurred when the detection concentration of praziquantel was within a range of 0. 2~10mg/ml( r = 0.9 999), the average recovery of which was (102.44 ± 0.69)%. CONCLUSION: The design of the formula is reasonable; the preparation process is reliable and the method for assaying is simple, fast and accurate.
作者 张洪 申献玲
出处 《中国药房》 CAS CSCD 北大核心 2005年第22期1710-1712,共3页 China Pharmacy
关键词 吡喹酮 水凝胶栓剂 正交设计 泊洛沙姆 含量测定 Praziquantel Aquogel suppository Orthogonal design Poloxamer Content dertermination
  • 相关文献

参考文献4

  • 1Choi HG,Jong JH,Ryu JM,et al. Development of in situgelling and mucoadhensive acetaminophen liquid suppository [J ]. Int J Pharm, 1998,165: 33.
  • 2Miyazaki S,Nakamura T,Takada M. Thermo-sensitive sol - gel transition of pluronic F - 127 [J ]. Yakuzaigaku, 1991,51:36.
  • 3Schmolka IR. Artificial skin :Preparation and properties of pluronic F- 127 gels for treatment of burns[J] .J Biomed Mater Res, 1982,6: 571.
  • 4沈承武,房广星,张桂芳,张辉.环境敏感性水凝胶的研究进展及其在给药系统中的应用[J].齐鲁药事,2004,23(5):40-44. 被引量:8

二级参考文献22

  • 1YoshidaR,王亚敏.使用亲水凝胶制备的脉冲式给药系统[J].国外医学(药学分册),1994,21(4):221-224. 被引量:6
  • 2Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery[J]. Adv Drug Delivery Rev 2001,53:321 ~ 339.
  • 3Bromberg LE, Ron ES. Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery[J]. Adv Drug Deliv Rev 1998,31:197 ~ 221.
  • 4Gutowska A, Bark JS, Kwon IC, et al. Squeezing hydrogels for controlled oral drug delivery[J].J Controlled Release,1997,48:141 ~148.
  • 5Jeong B, Bae YH , Kim SW. Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers[J]. J Controlled Release,2000,63:155~ 163.
  • 6Jeong B, Choi YK, Bae YH, et al. New biodegradable polymers for injectable drug delivery systems [J]. J Controlled Release,1999,62:109 ~ 114.
  • 7Bilia A, Carelli V, Colo GD, et al. In vitro evaluation of a pHsensitive hydrogel for control of GI drug delivery from siliconebased matrices[J]. Int J Pharrn, 1996,130 :83 ~ 92.
  • 8Carelli V, Coltelli S, Colo GD, et al. Silicone microspheres for pH-controlled gastrointestinal drug delivery[J]. Int J Pharm,1999,179:73 ~ 83.
  • 9Dong L, Hoffman AS. A novel approach for preparation of pHsensitive hydrogels for enteric drug delivery[J]. J Controlled Release,1991,15:141 ~ 152.
  • 10Brazel CS, Peppas NA. Pulsatile local delivery of thrombolytic and antithrombotic agents using poly(N-isopropylacrylamideco-methacrylic acid) hydrogels[J]. J Controlled Release, 1996,3957 ~ 64.

共引文献7

同被引文献58

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部